USMV vs XBI
iShares MSCI USA Min Vol Factor ETF vs SPDR S&P Biotech ETF
- • USMV has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • USMV pays a higher dividend yield (1.50%).
Side-by-side metrics
| Metric | USMV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.50% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $23.01B | $10.73B |
YTD return | 4.46% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.48 | 1.10 |
P/E ratio | 24.18 | — |
Last price | $97.60 | $164.28 |
Inception | — | — |
Issuer | iShares | State Street |
USMV top holdings
| APH | Amphenol Corp Class A | 1.76% |
| JNJ | Johnson & Johnson | 1.55% |
| VRTX | Vertex Pharmaceuticals Inc | 1.54% |
| WELL | Welltower Inc | 1.54% |
| CB | Chubb Ltd | 1.52% |
| CSCO | Cisco Systems Inc | 1.50% |
| SO | Southern Co | 1.48% |
| DUK | Duke Energy Corp | 1.48% |
| BRK-B | Berkshire Hathaway Inc Class B | 1.46% |
| WM | Waste Management Inc | 1.38% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About USMV
USMV (iShares MSCI USA Min Vol Factor ETF) is US stocks selected for lower volatility. Managed by iShares, the fund carries $23.0B in assets under management, an expense ratio of 0.15%, a dividend yield of 1.50%. Its largest holding is Amphenol Corp Class A (APH), which represents 1.8% of the portfolio. Real Estate is the fund's largest sector exposure at 2.6%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.